ERVW-1 and infection: As both a prolonged antibody maturation process and presence of rare antibody characteristics are required for bNAb development during natural infection in humans, the selection of appropriate Env trimers for immunization with a specifically designed regimen to achieve optimal vaccine response remains challenging.